Steven Lieberman

Rothwell, Figg, Ernst & Manbeck, P.C.

Steven is a shareholder at the Washington, D.C. intellectual property firm of Rothwell, Figg, Ernst & Manbeck, P.C. He has been litigating patent and other intellectual property cases since 1991, and he has served as lead counsel in numerous lawsuits in the pharmaceutical, biotech, veterinary, and medical products fields, including handling more than 30 Hatch-Waxman litigations. Steven has experience representing both generic and brand name companies across district courts, the Federal Circuit, and the International Trade Commission. He also handles and argues post-grant proceedings (IPRs and CBMs) created by the America Invents Act, and he regularly advises clients on biosimilars issues. Steven received a B.A. degree from Princeton University, summa cum laude, in 1980 and a J.D. degree from Columbia University Law School in 1984.